Vitamin D in Americantitis population

Year : 2025 | Volume : 15 | Issue : 01 | Page : 7 10
    By

    Priyanka Verma,

  1. Research Officer, Department of Biochemistry, Regional Research Institute of Unani Medicine, New Delhi, India

Abstract

Neurasthenia is also known as Americantitis or nervosism where there is mechanical weakness of the nerves, characterised with symptoms like fatigue, anxiety, headache, heart palpitations, high blood pressure and depressed mood. Vitamin D is increasingly recognized as a critical nutrient with significant roles in various physiological systems, including the nervous, immune, and muscular systems. Emerging research highlights its direct impact on brain health, underscoring the importance of adequate Vitamin D levels for maintaining cognitive and emotional well-being. A recent study aimed to investigate the possible link between Vitamin D deficiency and neurasthenia, a condition marked by both physical and mental fatigue. To validate this connection, researchers employed a rigorous approach by estimating Vitamin D levels in 41 individuals diagnosed with neurasthenia. Using the Chemiluminescence Immunoassay (CLIA) method, a precise and reliable technique for measuring vitamin concentrations, they observed that the mean Vitamin D levels in these patients were significantly lower than those typically found in the general population. These findings suggest a strong correlation between insufficient Vitamin D levels and the symptoms of neurasthenia, paving the way for further investigation into whether supplementation or dietary adjustments could alleviate the condition.

Keywords: Neurasthenia, Vitamin D, Fatigue, Anxiety, Headache.

[This article belongs to Research and Reviews: A Journal of Neuroscience ]

How to cite this article:
Priyanka Verma. Vitamin D in Americantitis population. Research and Reviews: A Journal of Neuroscience. 2025; 15(01):7-10.
How to cite this URL:
Priyanka Verma. Vitamin D in Americantitis population. Research and Reviews: A Journal of Neuroscience. 2025; 15(01):7-10. Available from: https://journals.stmjournals.com/rrjons/article=2025/view=198184


References

  1. Van Deusen EH. Observations on a form of nervous prostration (neurasthenia) culminating in insanity. Am J Insanity. 1869;25(4):445–61.
  2. Beard G. Neurasthenia or nervous exhaustion. Boston Med Surg J. 1869;80(13):217–21.
  3. Connor H. Doctors and “Educational Overpressure” in Nineteenth-Century Britain: A Fatigue State that Divided Medical Opinion. Eur J Hist Med Health. 2022 Oct 20; -1(aop):3–38.
  4. World Health Organization. ICD-11 for Mortality and Morbidity Statistics [Internet]. Geneva: World Health Organization; 2023 [cited 2023 Apr 24]. Available from: https://icd.who.int
  5. Dimsdale JE, Xin Y, Kleinman A, Patel V, Narrow WE, Sirovatka PJ, et al. Somatic Presentations of Mental Disorders: Refining the Research Agenda for DSM-V. Arlington (VA): American Psychiatric Publishing; 2009. p. 58.
  6. Groves NJ, McGrath JJ, Burne THJ. Vitamin D as a neurosteroid affecting the developing and adult brain. Annu Rev Nutr. 2014; 34:117–41.
  7. Harms LR, Burne THJ, Eyles DW, McGrath JJ. Vitamin D and the brain. Best Pract Res Clin Endocrinol Metab. 2011 Aug;25(4):657–69.
  8. Kesby JP, Eyles DW, Burne THJ, McGrath JJ. The effects of vitamin D on brain development and adult brain function. Mol Cell Endocrinol. 2011 Dec 5;347(1-2):121–7.
  9. DeLuca GC, Kimball SM, Kolasinski J, Ramagopalan SV, Ebers GC. The role of vitamin D in nervous system health and disease. Neuropathol Appl Neurobiol. 2013 Feb;39(5):458–84.
  10. Fernandes de Abreu DA, Eyles DW, Feron F. Vitamin D, a neuro-immunomodulator: Implications for neurodegenerative and autoimmune diseases. Psychoneuroendocrinology. 2009 Dec;34(Suppl 1):S265–77.
Regular Issue Subscription Original Research
Volume 15
Issue 01
Received 20/11/2024
Accepted 23/12/2024
Published 13/02/2025
Publication Time 85 Days
145

Login


My IP

PlumX Metrics